SanaClis is Once Again a Proud Partner Member of Medicines for Europe
1 minute read
Medicines for Europe signifies the pharmaceutical companies supplying the major share of medicines across Europe and acts as the voice of the generic, biosimilar and value-added industries. As an organization focused on providing access to safe, high-quality medicines for all, Medicines for Europe plays a crucial role in improving the health and well-being of people across the continent.
As a member of Medicines for Europe, SanaClis is part of a community of like-minded individuals who are committed to making a positive impact. Together, we are working towards a common goal of improving access to medicines and creating a healthier future for all. Better access to the most effective therapies means millions more patients are getting better and living longer, while healthcare inequalities are being reduced. Through our partnership, we aim to make a real difference to patients, ensuring they have access to the treatments they need, while we play our part in the sustainability and competitiveness of our industry.
We take great pride in being a member of such a strong and united association, and look forward to continuing to work hand-in-hand to make a real difference to the lives of patients across Europe.